Gender differences in a clinical trial for prescription opioid dependence

Journal of Substance Abuse Treatment

Volumn 45, Issue 1, 2013, Pages 38-43

  McHugh, R Kathryn ^a,b   DeVito, Elise E ^c   Dodd, Dorian ^a   Carroll, Kathleen M ^c   Potter, Jennifer Sharpe ^d   Greenfield, Shelly F ^a,b   Connery, Hilary Smith ^a,b   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Gender; Opioid dependence; Prescription opioids; Sex differences; Treatment outcome; Women

Indexed keywords

OPIATE;

ADULT; AFFECT; AGED; ALCOHOL ABUSE; ARTICLE; CLINICAL TRIAL (TOPIC); COPING BEHAVIOR; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALCOHOL-RELATED DISORDERS; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; PRESCRIPTION DRUG MISUSE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876993960     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.12.007     Document Type: Article

References (43)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Andrews G., Peters L. The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry and Psychiatric Epidemiology 1998, 33:80-88.
3. Back S.E., Lawson K.M., Singleton L.M., Brady K.T. Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors 2011, 36:829-834.
4. Back S.E., Payne R.L., Simpson A.N., Brady K.T. Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviors 2010, 35:1001-1007.
5. Back S.E., Payne R.L., Wahlquist A.H., Carter R.E., Stroud Z., Haynes L., Ling W. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. The American Journal of Drug and Alcohol Abuse 2011, 37:313-323.
6. Beck A.T., Steer R.A., Ball R., Ranieri W. Manual for the Beck Depression Inventory II 1996, Psychological Corporation, San Antonio, TX.
7. Birnbaum H.G., White A.G., Schiller M., Waldman T., Cleveland J.M., Roland C.L. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine 2011, 12:657-667.
8. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 2004, 73:199-207.
9. Cicero T.J., Lynskey M., Todorov A., Inciardi J.A., Surratt H.L. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 2008, 139:127-135.
10. Courvoisier D.S., Etter J.F. Comparing the predictive validity of five cigarette dependence questionnaires. Drug and Alcohol Dependence 2010, 107:128-133.
11. Gjeilo K.H., Stenseth R., Wahba A., Lydersen S., Klepstad P. Validation of the brief pain inventory in patients six months after cardiac surgery. Journal of Pain and Symptom Management 2007, 34:648-656.
12. Green T.C., Grimes Serrano J.M., Licari A., Budman S.H., Butler S.F. Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug and Alcohol Dependence 2009, 103:65-73.
13. Greenfield S.F., Brooks A.J., Gordon S.M., Green C.A., Kropp F., McHugh R.K., Miele G.M. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence 2007, 86:1-21.
14. Grella C.E., Karno M.P., Warda U.S., Niv N., Moore A.A. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addictive Behaviors 2009, 34:498-504.
15. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
16. Hernandez-Avila C.A., Rounsaville B.J., Kranzler H.R. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence 2004, 74:265-272.
17. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J. Trends in medical use and abuse of opioid analgesics. Journal of the American Medical Association 2000, 283:1710-1714.
18. Keller S., Bann C.M., Dodd S.L., Schein J., Mendoza T.R., Cleeland C.S. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. The Clinical Journal of Pain 2004, 20:309-318.
19. Keyes K.M., Martins S.S., Blanco C., Hasin D.S. Telescoping and gender differences in alcohol dependence: New evidence from two national surveys. The American Journal of Psychiatry 2010, 168:969-976.
20. Lykke J., Hesse M., Austin S.F., Oestrich I. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addictive Behaviors 2008, 33:292-300.
21. Maremmani I., Stefania C., Pacini M., Maremmani A.G., Carlini M., Golia F., Dell'Osso L. Differential substance abuse patterns distribute according to gender in heroin addicts. Journal of Psychoactive Drugs 2010, 42:89-95.
22. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: Origins, contributions and transitions. The American Journal on Addictions 2006, 15:113-124.
23. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Argeriou M. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9:199-213.
24. Monti P.M., Rohsenow D.J., Colby S.M., Abrams D.B. Smoking among alcoholics during and after treatment: Implications for models, treatment strategies, and policy. Alcohol and tobacco: From basic science to clinical practice 1995, Bethesda, MD, National Institute of Alcohol Abuse and Addiction. J.B. Fertig, J.P. Allen (Eds.).
25. Parsells Kelly J., Cook S.F., Kaufman D.W., Anderson T., Rosenberg L., Mitchell A.A. Prevalence and characteristics of opioid use in the US adult population. Pain 2008, 138:507-513.
26. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety 2006, 15:618-627.
27. Randall C.L., Roberts J.S., Del Boca F.K., Carroll K.M., Connors G.J., Mattson M.E. Telescoping of landmark events associated with drinking: A gender comparison. Journal of Studies on Alcohol 1999, 60:252-260.
28. Rubonis A.V., Colby S.M., Monti P.M., Rohsenow D.J., Gulliver S.B., Sirota A.D. Alcohol cue reactivity and mood induction in male and female alcoholics. Journal of Studies on Alcohol 1994, 55:487-494.
29. Sidak Z. Rectangular confidence region for the means of multivariate normal distributions. Journal of the American Statistical Association 1967, 62:626-633.
30. Smyth B.P., Fagan J., Kernan K. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. Journal of Substance Abuse Treatment 2012, 42:35-44.
31. Sordo L., Chahua M., Bravo M.J., Barrio G., Brugal M.T., Domingo-Salvany A., De la Fuente L. Depression among regular heroin users: The influence of gender. Addictive Behaviors 2012, 37:148-152.
32. Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration.
33. Tan G., Jensen M.P., Thornby J.I., Shanti B.F. Validation of the Brief Pain Inventory for chronic nonmalignant pain. The Journal of Pain 2004, 5:133-137.
34. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., Sullivan L.E. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 2008, 103:258-268.
35. Tompkins D.A., Bigelow G.E., Harrison J.A., Johnson R.E., Fudala P.J., Strain E.C. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug and Alcohol Dependence 2009, 105:154-159.
36. Turk D.C., Swanson K.S., Gatchel R.J. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. The Clinical Journal of Pain 2008, 24:497-508.
37. Weiss R.D., Griffin M.L., Hufford C. Craving in hospitalized cocaine abusers as a predictor of outcome. The American Journal of Drug and Alcohol Abuse 1995, 21:289-301.
38. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011, 68:1238-1246.
39. Weiss R.D., Potter J.S., Provost S.E., Huang Z., Jacobs P., Hasson A., Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials 2010, 31:189-199.
40. World Health Organization Composite International Diagnostic Interview (CIDI): Core Version 2.1 1997, World Health Organization, Geneva, Switzerland.
41. Wu L., Woody G.E., Yang C., Blazer D.G. Subtypes of nonmedical opioid users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 2010, 112:69-80.
42. Wu L.T., Ling W., Burchett B., Blazer D.G., Shostak J., Woody G.E. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. Substance Abuse and Rehabilitation 2010, 1:13-22.
43. Ziedonis D.M., Amass L., Steinberg M., Woody G., Krejci J., Annon J.J., Ling W. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug and Alcohol Dependence 2009, 99:28-36.